International Society of Blood Transfusion Working Party on red cell immunogenetics and blood group terminology: Cancun report (2012)

Vox Sanguinis

Volumn 107, Issue 1, 2014, Pages 90-96

  Storry, J R ^a   Castilho, L ^b   Daniels, G ^c   Flegel, W A ^d   Garratty, G ^e   de Haas, M ^f   Hyland, C ^g   Lomas Francis, C ^h   Moulds, J M ⁱ   Nogues, N ^j   Olsson, M L ^k   Poole, J ^c   Reid, M E ^h   Rouger, P ^l   van der Schoot, E ^d   Scott, M ^c   Tani, Y ^m   Yu, L C ⁿ   Wendel, S ^o   Westhoff, C ^h   Yahalom, V ^p   Zelinski, T ^q   more..

^a University and Regional Laboratories   (Sweden)

^b UNIVERSITY OF CAMPINAS   (Brazil)

^c NHS BLOOD AND TRANSPLANT   (United Kingdom)

^d CLINICAL CENTER   (United States)

^e AMERICAN RED CROSS BLOOD SERVICES   (United States)

^f CENTRAL LABORATORY   (Netherlands)

^g Australian Red Cross   (Australia)

^h NEW YORK BLOOD CENTER   (United States)

ⁱ LifeShare Blood Centers   (United States)

^j BANC DE SANG I TEIXITS   (Spain)

^k LUND UNIVERSITY   (Sweden)

^l Centre National de Référence pour les Groupes sanguines   (France)

^m Block Blood Centre   (Japan)

ⁿ MACKAY MEMORIAL HOSPITAL   (Taiwan)

^o HOSPITAL SÍRIO LIBANÊS   (Brazil)

^p MAGEN DAVID ADOM   (Israel)

^q Rh Laboratory   (Canada)

more..

Author keywords

Blood groups; Genetics; Red blood cell; Terminology

Indexed keywords

ABC TRANSPORTER; BREAST CANCER RESISTANCE PROTEIN; CHYMOTRYPSIN A; DECAY ACCELERATING FACTOR; PORPHYRIN; RHESUS D ANTIBODY; BLOOD GROUP ANTIGEN;

ALLELE; AMINO ACID SUBSTITUTION; ANTIGEN SPECIFICITY; ARTICLE; BLOOD GROUP ABO SYSTEM; BLOOD GROUP FORS SYSTEM; BLOOD GROUP JR SYSTEM; BLOOD GROUP KELL SYSTEM; BLOOD GROUP LAN SYSTEM; BLOOD GROUP RHESUS SYSTEM; BLOOD GROUP SYSTEM; BLOOD TRANSFUSION; CRYSTAL STRUCTURE; ERYTHROCYTE; ERYTHROCYTE MEMBRANE; EXCHANGE BLOOD TRANSFUSION; EXON; GENE MUTATION; HAPLOTYPE; HEMOLYTIC ANEMIA; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; IMMUNOGENETICS; MISSENSE MUTATION; NOMENCLATURE; NULL ALLELE; PHENOTYPE; PRIORITY JOURNAL; STOP CODON; CLASSIFICATION; GENETICS; HEALTH CARE ORGANIZATION; IMMUNOLOGY;

BLOOD GROUP ANTIGENS; HUMANS; IMMUNOGENETICS; SOCIETIES, SCIENTIFIC; TERMINOLOGY AS TOPIC;

EID: 84900467548     PISSN: 00429007     EISSN: 14230410     Source Type: Journal    
DOI: 10.1111/vox.12127     Document Type: Article

References (29)

1. Suchanowska A, Kaczmarek R, Duk M, et al.: A single point mutation in the gene encoding Gb3/CD77 synthase causes a rare inherited polyagglutination syndrome. J Biol Chem 2012; 287:38220-38230
2. Harris PA, Roman GK, Moulds JJ, et al.: An inherited RBC characteristic, NOR, resulting in erythrocyte polyagglutination. Vox Sang 1982; 42:134-140
3. Scharberg AK, Kanbur N, Baudendistel R, et al.: PARG: a new low prevalence RH blood group antigen. Vox Sang 2012; 103(Suppl. 1):57
4. Peyrard TP, Pham B, Jusczak G, et al.: The "Anti-e" and antibody to a high-prevalence Rh antigen made by RHCE*ceMO/RHCE*cE and RHCE ceMO/RHCE ceMO people are not anti-hrS/anti-hrB nor anti-Hr/anti-HrB respectively. Transfusion 2010; 50:144A
5. Karamatic Crew V, Poole J, Bullock T, et al.: KETI, a novel high incidence antigen in the Kell blood group system: a serological and molecular study. Vox Sang 2011; 101(Suppl. 1):19
6. Reid ME, Velliquette RW, Lomas-Francis C: Weakened expression of K11 on RBCS lacking KANT (KEL33), and KETI (KEL36). Vox Sang 2012; 103(Suppl. 1):217
7. Vege S, Lomas-Francis C, Velliquette RW, et al.: A new high prevalence antigen (KHUL) in the Kell blood group system. Transfusion 2011; 51(Suppl):25A
8. Uchikawa M, Onodera T, Ogasawara K, et al.: Molecular basis for a novel low-frequency antigen in the Kell blood group system, KYO. Vox Sang 2006; 91(Suppl. 1):136
9. Lomas-Francis CF, Fuchisawa A, Uchikawa M, et al.: A new high prevalence Kell antigen KYOR, antithetical to the low-prevalence antigen KYO, is the second trypsin-sensitive Kell antigen. Transfusion 2012; 52(Suppl):158A
10. Karamatic Crew V, Poole J, Marais I, et al.: DOLG, a novel high incidence antigen in the Dombrock blood group system. Vox Sang 2011; 101(Suppl. 1): 263
11. Lomas-Francis CF, Fuchisawa A, Hamilton J, et al.: CRAG: a new high-prevalence antigen in the Cromer blood group system. Vox Sang 2012; 103(Suppl. 1):211-212
12. Poole J, Grimsley S, Ligthart P, et al.: A novel RHAG blood group antigen associated with severe HDFN. Vox Sang 2011; 101(Suppl. 1):70
13. Huang CH, Cheng G, Liu Z, et al.: Molecular basis for Rh(null) syndrome: identification of three new missense mutations in the Rh50 glycoprotein gene. Am J Hematol 1999; 62:25-32
14. Tilley L, Green C, Poole J, et al.: A new blood group system, RHAG: three antigens resulting from amino acid substitutions in the Rh-associated glycoprotein. Vox Sang 2010; 98:151-159
15. Hult AK, Svensson L, Stamps R, et al.: Forssman expression on human red cells: biochemical and genetic basis of a novel histo-blood group system candidate. Transfusion 2011; 51(Suppl):1A
16. Svensson L, Hult AK, Stamps R, et al.: Forssman expression on human erythrocytes: biochemical and genetic evidence of a new histo-blood group system. Blood 2013; 121:1459-1468
17. Stamps R, Sokol RJ, Leach M, et al.: A new variant of blood group A. Apae. Transfusion 1987; 27:315-318
18. Patenaude SI, Seto NO, Borisova SN, et al.: The structural basis for specificity in human ABO(H) blood group biosynthesis. Nat Struct Biol 2002; 9:685-690
19. Yamamoto M, Cid E, Yamamoto F: Molecular genetic basis of the human Forssman glycolipid antigen negativity. Sci Rep 2012; 2:975
20. Zelinski T, Coghlan G, Liu XQ, et al.: ABCG2 null alleles define the Jr(a-) blood group phenotype. Nat Genet 2012; 44:131-132
21. Saison C, Helias V, Ballif BA, et al.: Null alleles of ABCG2 encoding the breast cancer resistance protein define the new blood group system Junior. Nat Genet 2012; 44:174-177
22. Robey RW, To KK, Polgar O, et al.: ABCG2: a perspective. Adv Drug Deliv Rev 2009; 61:3-13
23. Helias V, Saison C, Ballif BA, et al.: ABCB6 is dispensable for erythropoiesis and specifies the new blood group system Langereis. Nat Genet 2012; 44:170-173
24. Zelinski T, Hue-Roye K, Huang A, et al.: Molecular characterization of alleles of the Lan blood group system. Transfusion 2012; 52:42A-43A
25. Saison C, Helias V, Peyrard T, et al.: The ABCB6 mutation p.Arg192Trp is a recessive mutation causing the Lan-blood type. Vox Sang 2013; 104:159-165
26. Krishnamurthy P, Schuetz JD: The role of ABCG2 and ABCB6 in porphyrin metabolism and cell survival. Curr Pharm Biotechnol 2011; 12:647-655
27. Karamatic Crew V, Poole J, Mathlouthi R, et al.: A novel Cromer blood group system antigen, CRUE, arising from two heterozygous DAF mutations in one individual with the corresponding anti-CRUE. Vox Sang 2012; 103(Suppl. 1):56
28. Hue-Roye K, Lomas-Francis C, Coghlan G, et al.: The JR blood group system (ISBT 032): molecular characterization of three new null alleles. Transfusion 2013; 53:1575-1579
29. Hue-Roye K, Zelinski T, Cobaugh A, et al.: The JR blood group system: identification of alleles that alter expression. Transfusion 2013; 53:2710-2714